Optimise efficiency of your gene therapy or vaccine development
04 Jun, 2021 | Newsletters
|Viral capsids like the lentivirus, rAAV and Adenovirus vectors are increasingly used as vectors in gene therapy and vaccines (including those for Covid-19). To develop efficient virally-vectored therapies, extensive characterisation needs to be done from measuring capsid size & count, % full, aggregate formation, stability, genome release and capsid charge. |
Join this webinar series of “Ask an Expert”
Expand your application knowledge of various techniques from Dynamic Light Scattering (DLS), Differential Scanning Calorimetry (DSC), Nanoparticle Tracking Analysis (NTA) and multi-detection SEC (SEC-MALS)
Learn using case study examples and analysis
REGISTER FOR THE LIVE WEBINARS OR TO RECEIVE A RECORDING
Webinar 1: Efficient development of gene therapy and vaccines through comprehensive viral vector characterisation.
Webinar 2: Quantifying rAAV with Multi-angle DLS and nanoparticle tracking analysis.
Webinar 3: Optimising loading time and stability of Virally Vectored therapies and vaccines using SEC and DSC.
Complementary technologies for enhanced characterisation and generation of multi-parametral stability profile of rAAV samples.
|Contact us for a demo|
Request a quote now
Email us for more info